Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profiling

7 Sept 2018

Abstract excerpt

// Khalid N. Al-Zahrani 1, 2 , David P. Cook 1, 2 , Barbara C. Vanderhyden 1, 2 and Luc A. Sabourin 1, 2 1 Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario, Canada 2 Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada Correspondence to: Luc A. Sabourin, email: lsabourin@ohri.ca Keywords: androgen receptor; Sox10; bioinformatics;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Cancer Cells and Metastasis
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30279965
DOI: 10.18632/oncotarget.26072

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profilingPMID 30279965Read ↗

Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?Semantic proximity Read ↗

Molecular Profiling of a Triple-negative Breast Cancer Cohort in India for EGFR and AR expression analyzed for patient outcomes showed a distinct subset of cellular co-expressionSemantic proximity Read ↗

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.Semantic proximity Read ↗

Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancerSemantic proximity Read ↗

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast CancerSemantic proximity Read ↗

FOXC1 and SOX10 in Estrogen Receptor-Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction.Semantic proximity Read ↗

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancersSemantic proximity Read ↗

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expressionSemantic proximity Read ↗

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Semantic proximity Read ↗

<i>SERPINA1</i>is a direct estrogen receptor target gene and a predictor of survival in breast cancer patientsSemantic proximity Read ↗

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancerSemantic proximity Read ↗

SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.